Home base-compensating R&D: Indicators, public policy, and ramifications for multinational firms

The situation in which a multinational firm compensates for comparative weakness in home-country R&D by locating vital R&D activities in foreign countries with a stronger R&D base has generally been considered a fairly marginal phenomenon. Yet home base-compensating R&D by MNCs is mo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of international management 2011-03, Vol.17 (1), p.42-53
Hauptverfasser: Lehrer, Mark, Asakawa, Kazuhiro, Behnam, Michael
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 53
container_issue 1
container_start_page 42
container_title Journal of international management
container_volume 17
creator Lehrer, Mark
Asakawa, Kazuhiro
Behnam, Michael
description The situation in which a multinational firm compensates for comparative weakness in home-country R&D by locating vital R&D activities in foreign countries with a stronger R&D base has generally been considered a fairly marginal phenomenon. Yet home base-compensating R&D by MNCs is more prevalent and more important in its effects than generally assumed. Given intensifying competition among nations for R&D investment by MNCs, home base-compensating R&D may help stimulate R&D reform in the home country, as illustrated with the example of German biotechnology. The probability that home base-compensating R&D can stimulate R&D reform in the firm's home country is highest when practiced by “high-profile players” in sectors that are science-based and that are either strategic (inter-industry economic and knowledge spillovers), feature above-average growth, and/or are of high political importance. To the extent that home base-compensating R&D by MNCs can potentially encourage policy reforms in their home country, this adds a new level of complexity to discussions about the role of corporations in influencing public policy as a component of their corporate social responsibility.
doi_str_mv 10.1016/j.intman.2010.08.001
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_854373091</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S107542531000061X</els_id><sourcerecordid>854373091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c434t-497cc889065e6bc171a017b8db9db86fa69a7b102719f4d9a64f6e9aaf420f823</originalsourceid><addsrcrecordid>eNp9UMFq3DAUNKGFpmn-oAedmku8fbJlS8qhENI2GwgUSnNWZfkp1WJJruQN7N9XW4ccc5j3HsPM8Jiq-khhQ4H2n3cbFxavw6aBQoHYANCT6pQK3tbQN_Cm3MC7mjVd-656n_MOABop5Gn1exs9kkFnrE30M4asFxceyc9PX6_IXRid0UtM-ZLM-2FyhsyxzMMl0WEkSXtnjwIXQyY2JuL3U3H_J_RErEs-f6jeWj1lPH_eZ9XD92-_brb1_Y_bu5vr-9qwli01k9wYIST0HfaDoZxqoHwQ4yDHQfRW91LzgULDqbRslLpntkeptWUNWNG0Z9XFmjun-HePeVHeZYPTpAPGfVaiYy1vQdKiZKvSpJhzQqvm5LxOB0VBHftUO7X2qY59KhCq9Fls29WWcEbz4kHEZ_GTajXlZRwKipOW5Y5cwVzAGtW16s_iS9SXNQpLIU8Ok8rGYTA4uoRmUWN0r__yD4tomdQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>854373091</pqid></control><display><type>article</type><title>Home base-compensating R&amp;D: Indicators, public policy, and ramifications for multinational firms</title><source>RePEc</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Lehrer, Mark ; Asakawa, Kazuhiro ; Behnam, Michael</creator><creatorcontrib>Lehrer, Mark ; Asakawa, Kazuhiro ; Behnam, Michael</creatorcontrib><description><![CDATA[The situation in which a multinational firm compensates for comparative weakness in home-country R&D by locating vital R&D activities in foreign countries with a stronger R&D base has generally been considered a fairly marginal phenomenon. Yet home base-compensating R&D by MNCs is more prevalent and more important in its effects than generally assumed. Given intensifying competition among nations for R&D investment by MNCs, home base-compensating R&D may help stimulate R&D reform in the home country, as illustrated with the example of German biotechnology. The probability that home base-compensating R&D can stimulate R&D reform in the firm's home country is highest when practiced by “high-profile players” in sectors that are science-based and that are either strategic (inter-industry economic and knowledge spillovers), feature above-average growth, and/or are of high political importance. To the extent that home base-compensating R&D by MNCs can potentially encourage policy reforms in their home country, this adds a new level of complexity to discussions about the role of corporations in influencing public policy as a component of their corporate social responsibility.]]></description><identifier>ISSN: 1075-4253</identifier><identifier>EISSN: 1873-0620</identifier><identifier>DOI: 10.1016/j.intman.2010.08.001</identifier><language>eng</language><publisher>Elsevier Inc</publisher><subject>Biotechnology ; Business strategies ; Compensation ; Competition ; Germany ; Home base-compensating R&amp;D ; Home base-compensating R&amp;D Multinational corporations National systems of innovation R&amp;D reform Public policy Germany Biotechnology ; Investment ; Knowledge transfer ; Multinational corporations ; Multinational enterprises ; National systems of innovation ; Public policy ; R&amp;D reform ; Research and development</subject><ispartof>Journal of international management, 2011-03, Vol.17 (1), p.42-53</ispartof><rights>2010 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c434t-497cc889065e6bc171a017b8db9db86fa69a7b102719f4d9a64f6e9aaf420f823</citedby><cites>FETCH-LOGICAL-c434t-497cc889065e6bc171a017b8db9db86fa69a7b102719f4d9a64f6e9aaf420f823</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.intman.2010.08.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,4006,27923,27924,45994</link.rule.ids><backlink>$$Uhttp://econpapers.repec.org/article/eeeintman/v_3a17_3ay_3a2011_3ai_3a1_3ap_3a42-53.htm$$DView record in RePEc$$Hfree_for_read</backlink></links><search><creatorcontrib>Lehrer, Mark</creatorcontrib><creatorcontrib>Asakawa, Kazuhiro</creatorcontrib><creatorcontrib>Behnam, Michael</creatorcontrib><title>Home base-compensating R&amp;D: Indicators, public policy, and ramifications for multinational firms</title><title>Journal of international management</title><description><![CDATA[The situation in which a multinational firm compensates for comparative weakness in home-country R&D by locating vital R&D activities in foreign countries with a stronger R&D base has generally been considered a fairly marginal phenomenon. Yet home base-compensating R&D by MNCs is more prevalent and more important in its effects than generally assumed. Given intensifying competition among nations for R&D investment by MNCs, home base-compensating R&D may help stimulate R&D reform in the home country, as illustrated with the example of German biotechnology. The probability that home base-compensating R&D can stimulate R&D reform in the firm's home country is highest when practiced by “high-profile players” in sectors that are science-based and that are either strategic (inter-industry economic and knowledge spillovers), feature above-average growth, and/or are of high political importance. To the extent that home base-compensating R&D by MNCs can potentially encourage policy reforms in their home country, this adds a new level of complexity to discussions about the role of corporations in influencing public policy as a component of their corporate social responsibility.]]></description><subject>Biotechnology</subject><subject>Business strategies</subject><subject>Compensation</subject><subject>Competition</subject><subject>Germany</subject><subject>Home base-compensating R&amp;D</subject><subject>Home base-compensating R&amp;D Multinational corporations National systems of innovation R&amp;D reform Public policy Germany Biotechnology</subject><subject>Investment</subject><subject>Knowledge transfer</subject><subject>Multinational corporations</subject><subject>Multinational enterprises</subject><subject>National systems of innovation</subject><subject>Public policy</subject><subject>R&amp;D reform</subject><subject>Research and development</subject><issn>1075-4253</issn><issn>1873-0620</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>X2L</sourceid><recordid>eNp9UMFq3DAUNKGFpmn-oAedmku8fbJlS8qhENI2GwgUSnNWZfkp1WJJruQN7N9XW4ccc5j3HsPM8Jiq-khhQ4H2n3cbFxavw6aBQoHYANCT6pQK3tbQN_Cm3MC7mjVd-656n_MOABop5Gn1exs9kkFnrE30M4asFxceyc9PX6_IXRid0UtM-ZLM-2FyhsyxzMMl0WEkSXtnjwIXQyY2JuL3U3H_J_RErEs-f6jeWj1lPH_eZ9XD92-_brb1_Y_bu5vr-9qwli01k9wYIST0HfaDoZxqoHwQ4yDHQfRW91LzgULDqbRslLpntkeptWUNWNG0Z9XFmjun-HePeVHeZYPTpAPGfVaiYy1vQdKiZKvSpJhzQqvm5LxOB0VBHftUO7X2qY59KhCq9Fls29WWcEbz4kHEZ_GTajXlZRwKipOW5Y5cwVzAGtW16s_iS9SXNQpLIU8Ok8rGYTA4uoRmUWN0r__yD4tomdQ</recordid><startdate>20110301</startdate><enddate>20110301</enddate><creator>Lehrer, Mark</creator><creator>Asakawa, Kazuhiro</creator><creator>Behnam, Michael</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>DKI</scope><scope>X2L</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8BJ</scope><scope>FQK</scope><scope>JBE</scope></search><sort><creationdate>20110301</creationdate><title>Home base-compensating R&amp;D: Indicators, public policy, and ramifications for multinational firms</title><author>Lehrer, Mark ; Asakawa, Kazuhiro ; Behnam, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c434t-497cc889065e6bc171a017b8db9db86fa69a7b102719f4d9a64f6e9aaf420f823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Biotechnology</topic><topic>Business strategies</topic><topic>Compensation</topic><topic>Competition</topic><topic>Germany</topic><topic>Home base-compensating R&amp;D</topic><topic>Home base-compensating R&amp;D Multinational corporations National systems of innovation R&amp;D reform Public policy Germany Biotechnology</topic><topic>Investment</topic><topic>Knowledge transfer</topic><topic>Multinational corporations</topic><topic>Multinational enterprises</topic><topic>National systems of innovation</topic><topic>Public policy</topic><topic>R&amp;D reform</topic><topic>Research and development</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lehrer, Mark</creatorcontrib><creatorcontrib>Asakawa, Kazuhiro</creatorcontrib><creatorcontrib>Behnam, Michael</creatorcontrib><collection>RePEc IDEAS</collection><collection>RePEc</collection><collection>CrossRef</collection><collection>International Bibliography of the Social Sciences (IBSS)</collection><collection>International Bibliography of the Social Sciences</collection><collection>International Bibliography of the Social Sciences</collection><jtitle>Journal of international management</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lehrer, Mark</au><au>Asakawa, Kazuhiro</au><au>Behnam, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Home base-compensating R&amp;D: Indicators, public policy, and ramifications for multinational firms</atitle><jtitle>Journal of international management</jtitle><date>2011-03-01</date><risdate>2011</risdate><volume>17</volume><issue>1</issue><spage>42</spage><epage>53</epage><pages>42-53</pages><issn>1075-4253</issn><eissn>1873-0620</eissn><abstract><![CDATA[The situation in which a multinational firm compensates for comparative weakness in home-country R&D by locating vital R&D activities in foreign countries with a stronger R&D base has generally been considered a fairly marginal phenomenon. Yet home base-compensating R&D by MNCs is more prevalent and more important in its effects than generally assumed. Given intensifying competition among nations for R&D investment by MNCs, home base-compensating R&D may help stimulate R&D reform in the home country, as illustrated with the example of German biotechnology. The probability that home base-compensating R&D can stimulate R&D reform in the firm's home country is highest when practiced by “high-profile players” in sectors that are science-based and that are either strategic (inter-industry economic and knowledge spillovers), feature above-average growth, and/or are of high political importance. To the extent that home base-compensating R&D by MNCs can potentially encourage policy reforms in their home country, this adds a new level of complexity to discussions about the role of corporations in influencing public policy as a component of their corporate social responsibility.]]></abstract><pub>Elsevier Inc</pub><doi>10.1016/j.intman.2010.08.001</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1075-4253
ispartof Journal of international management, 2011-03, Vol.17 (1), p.42-53
issn 1075-4253
1873-0620
language eng
recordid cdi_proquest_miscellaneous_854373091
source RePEc; ScienceDirect Journals (5 years ago - present)
subjects Biotechnology
Business strategies
Compensation
Competition
Germany
Home base-compensating R&D
Home base-compensating R&D Multinational corporations National systems of innovation R&D reform Public policy Germany Biotechnology
Investment
Knowledge transfer
Multinational corporations
Multinational enterprises
National systems of innovation
Public policy
R&D reform
Research and development
title Home base-compensating R&D: Indicators, public policy, and ramifications for multinational firms
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T01%3A38%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Home%20base-compensating%20R&D:%20Indicators,%20public%20policy,%20and%20ramifications%20for%20multinational%20firms&rft.jtitle=Journal%20of%20international%20management&rft.au=Lehrer,%20Mark&rft.date=2011-03-01&rft.volume=17&rft.issue=1&rft.spage=42&rft.epage=53&rft.pages=42-53&rft.issn=1075-4253&rft.eissn=1873-0620&rft_id=info:doi/10.1016/j.intman.2010.08.001&rft_dat=%3Cproquest_cross%3E854373091%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=854373091&rft_id=info:pmid/&rft_els_id=S107542531000061X&rfr_iscdi=true